Cargando…

Lifetime risk to progress from pre-diabetes to type 2 diabetes among women and men: comparison between American Diabetes Association and World Health Organization diagnostic criteria

INTRODUCTION: Pre-diabetes, a status conferring high risk of overt diabetes, is defined differently by the American Diabetes Association (ADA) and the WHO. We investigated the impact of applying definitions of pre-diabetes on lifetime risk of diabetes in women and men from the general population. RE...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Herpt, Thijs T W, Ligthart, Symen, Leening, Maarten J G, van Hoek, Mandy, Lieverse, Aloysius G, Ikram, M Arfan, Sijbrands, Eric J G, Dehghan, Abbas, Kavousi, Maryam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Clinical care/Education/Nutrition
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678236/ https://www.ncbi.nlm.nih.gov/pubmed/33214188 http://dx.doi.org/10.1136/bmjdrc-2020-001529

Ejemplares similares

Genetic susceptibility, obesity and lifetime risk of type 2 diabetes: The ARIC study and Rotterdam Study
por: Ligthart, Symen, et al.
Publicado: (2021)

ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study
por: de Vries, Paul S., et al.
Publicado: (2016)

Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: a prospective cohort study
por: Singh, Sunny S., et al.
Publicado: (2020)

Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study
por: Brahimaj, Adela, et al.
Publicado: (2017)

The effect of guideline revisions on vascular complications of type 2 diabetes
por: Heijmans, Ralph, et al.
Publicado: (2019)

Introduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes
por: van Herpt, Thijs T. W., et al.
Publicado: (2017)

The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study
por: van Herpt, Thijs T. W., et al.
Publicado: (2016)

Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons
por: van Hoek, M., et al.
Publicado: (2011)

Association of the IgG N-glycome with the course of kidney function in type 2 diabetes
por: Singh, Sunny S, et al.
Publicado: (2020)

Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus
por: Singh, Sunny S., et al.
Publicado: (2020)

Age at natural menopause and risk of type 2 diabetes: a prospective cohort study
por: Muka, Taulant, et al.
Publicado: (2017)

Thyroid Function and the Risk of Prediabetes and Type 2 Diabetes
por: Roa Dueñas, Oscar H, et al.
Publicado: (2022)

Effects of Eligibility Criteria on Patient Selection and Treatment Implications from 10 Multidomain Dementia Prevention Trials: A Population-Based Study
por: Licher, Silvan, et al.
Publicado: (2023)

Tobacco smoking is associated with DNA methylation of diabetes susceptibility genes
por: Ligthart, Symen, et al.
Publicado: (2016)

Plasma protein N-glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetes
por: Memarian, Elham, et al.
Publicado: (2021)

Metformin and statin use associate with plasma protein N-glycosylation in people with type 2 diabetes
por: Singh, Sunny S, et al.
Publicado: (2020)

Heart Rate Variability and Incident Type 2 Diabetes in General Population
por: Wang, Kan, et al.
Publicado: (2023)

Person-centered diabetes care and patient activation in people with type 2 diabetes
por: Rutten, Guy E H M, et al.
Publicado: (2020)

Primary prevention of cardiovascular disease: The past, present, and future of blood pressure- and cholesterol-lowering treatments
por: Leening, Maarten J. G., et al.
Publicado: (2018)

Trajectories of BMI Before Diagnosis of Type 2 Diabetes: The Rotterdam Study
por: Nano, Jana, et al.
Publicado: (2020)

Complexity of antidiabetic medication regimen is associated with increased diabetes-related distress in persons with type 2 diabetes mellitus
por: Luzuriaga, Maria, et al.
Publicado: (2021)

An RBP4 promoter polymorphism increases risk of type 2 diabetes
por: van Hoek, M., et al.
Publicado: (2008)

IDF2022-0579 Post COVID-19 diabetes project: Intensive cardio-renal-metabolic management for people living with type 2 diabetes (T2D)
por: Ahmad, E., et al.
Publicado: (2023)

Recruitment, retention, and training of people with type 2 diabetes as diabetes prevention mentors (DPM) to support a healthcare professional-delivered diabetes prevention program: the Norfolk Diabetes Prevention Study (NDPS)
por: Garner, Nikki J, et al.
Publicado: (2019)

Baseline characteristics of participants in the Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) Program
por: Yeung, Kar-Fu, et al.
Publicado: (2022)

Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study
por: Brahimaj, Adela, et al.
Publicado: (2019)

Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study
por: Chaker, Layal, et al.
Publicado: (2016)

Lifetime Duration of Depressive Disorders in Patients With Type 2 Diabetes
por: de Groot, Mary, et al.
Publicado: (2016)

Obesity and Life Expectancy with and without Diabetes in Adults Aged 55 Years and Older in the Netherlands: A Prospective Cohort Study
por: Dhana, Klodian, et al.
Publicado: (2016)

Awareness and knowledge of diabetic ketoacidosis in people with type 1 diabetes: a cross-sectional, multicenter survey
por: Hepprich, Matthias, et al.
Publicado: (2023)

Long-term metformin adherence in the Diabetes Prevention Program Outcomes Study
por: Walker, Elizabeth Arquin, et al.
Publicado: (2020)

Atypical diabetes: a diagnostic challenge
por: Sjöholm, Åke
Publicado: (2020)

Predicting Type 2 Diabetes Based on Polymorphisms From Genome-Wide Association Studies : A Population-Based Study
por: van Hoek, Mandy, et al.
Publicado: (2008)

Eye care providers’ emerging roles in early detection of diabetes and management of diabetic changes to the ocular surface: a review
por: Richdale, Kathryn, et al.
Publicado: (2020)

Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study
por: Wolffenbuttel, Bruce H. R., et al.
Publicado: (2022)

Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications
por: Ciardullo, Stefano, et al.
Publicado: (2020)

Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy in the general population: A population-based cohort study
por: Licher, Silvan, et al.
Publicado: (2019)

Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors
por: Chow, Erica, et al.
Publicado: (2023)

Carbohydrate-last meal pattern lowers postprandial glucose and insulin excursions in type 2 diabetes
por: Shukla, Alpana P, et al.
Publicado: (2017)

Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study
por: Leening, Maarten J G, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hnd82qq2bk3oeu3nqq58ckgpm2